Related Experiment Video
Updated: Jun 27, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
Multiple Myeloma and Peripheral Neuropathy in Myotonic Dystrophy Type 2 (DM2)
Melanie Walker1, Michael D Weiss, B Jane Distad
1From the Department of Neurology, University of Washington School of Medicine, Seattle, WA.
Abstract:
Myotonic dystrophy type 2 (DM2) is a phenotypically heterogeneous multisystem disorder, most dramatically involving the nervous system. Although multisystem involvement is common in this disease, we present a genetically proven DM2 patient with both peripheral neuropathy and blood dyscrasia, previously unreported in the literature, suggesting a distinct phenotype in this population. Routine electrophoresis in DM2 patients with neuropathy is recommended, and implications surrounding the etiology of peripheral neuropathy and paraproteinemia in DM2 are discussed.
More Related Videos
06:35In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
05:06Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy
Published on: July 14, 2023
Related Concept Videos
Diabetic Neuropathy
Multiple Sclerosis l: Introduction
Alterations in Muscle Tone lll
Satellite Stem Cells and Muscular Dystrophy
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Alterations in Muscle Tone ll